22.11.2010
- U.S. biotechnology firm Genzyme, which is fending off an $18.5 billion hostile takeover bid from France's Sanofi-Aventis, is considering a new deal structure that Sanofi has said...
22.11.2010
- AstraZeneca confirmed on Friday it was considering spinning off its Astra Tech dental implants and medical devices business and had hired JP Morgan Chase to help with a strategic...
10.11.2010
- French drugmaker Sanofi-Aventis said it has called on bid target Genzyme not to use defensive tactics to block a takeover of the U.S. biotech but to let shareholders decide on its...
29.10.2010
- Sanofi-Aventis expanded its consumer health business in China with a $520.6 million takeover, showing it remains in the market for smaller bolt-on deals as it tries to buy U.S...
22.10.2010
- Merck & Co and Sanofi-Aventis have begun selling parts of the businesses they are combining to form the world's largest animal-health operation, people familiar with the matter...
21.10.2010
- EU antitrust regulators plan to review drug patent settlements struck this year to delay cheaper generics going to market, as part of their crackdown on illegal deals, a senior...
20.10.2010
- France's Sanofi Aventis said on Wednesday that it had received the green light from U.S. antitrust regulators to take-over the U.S. biotech Genzyme. Sanofi said that the waiting...
18.10.2010
- Sanofi-Aventis' position remains unchanged regarding a $18.5 billion hostile offer for Genzyme, Sanofi Chief Executive Chris Viehbacher told Reuters on the sidelines of the Women's...
